Regular updates related to sourcing and the management of health products are available on this page.
-
13 June 2022
Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics. -
20 May 2022
New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India -
08 April 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on dia... -
17 March 2022
Global Health Supply Chain Dialogue
The Global Fund is organizing a Global Health Supply Chain Dialogue from 29 to 31 March 2022 under the theme “Building Resilient Supply Chains for Effective Pandemic Preparedness”. -
10 March 2022
Misleading CE Mark Documentation Certification Issued by Real Companies
Following an LFA verification of a Recipient’s procurement, the QA Team would like to bring to the attention of the procurement community that certain Personal Protective Equipment (PPE) products and medical devices, and related documents, prominentl... -
18 February 2022
Recalling US FDA Safety Communication on Pulse Oximeter Accuracy and Limitations
The U.S. Food and Drug Administration (FDA) has recently published a safety communication on Pulse Oximeter Accuracy and Limitations.